Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours

We present a retrospective analysis on a cohort of low-grade, node-negative patients showing that human epidermal growth factor receptor 2 (HER2) status significantly affects the survival in this otherwise very good prognostic group. Our results provide support for the use of adjuvant trastuzumab in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tovey, S M, Brown, S, Doughty, J C, Mallon, E A, Cooke, T G, Edwards, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653773/
https://www.ncbi.nlm.nih.gov/pubmed/19223897
http://dx.doi.org/10.1038/sj.bjc.6604940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653773/
https://www.ncbi.nlm.nih.gov/pubmed/19223897
http://dx.doi.org/10.1038/sj.bjc.6604940

Ejemplares similares